Operating Margin of Niagen Bioscience, Inc. from 30 Dec 2017 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
The operating margin measures the profit a company makes on a dollar of sales after accounting for the direct costs involved in earning those revenues.
Summary
Niagen Bioscience, Inc. quarterly and annual Operating Margin in % history and change rate from 30 Dec 2017 to 30 Sep 2025.
  • Niagen Bioscience, Inc. Operating Margin for the quarter ending 30 Sep 2025 was 15%, a 3074% increase year-over-year.
  • Niagen Bioscience, Inc. annual Operating Margin for 2024 was 7.8%.
  • Niagen Bioscience, Inc. annual Operating Margin for 2023 was -6.7%, a 74% increase from 2022.
  • Niagen Bioscience, Inc. annual Operating Margin for 2022 was -26%, a 36% increase from 2021.
Operating Margin, Quarterly (%)
Operating Margin, YoY Quarterly Change (%)
Operating Margin, Annual (%)
Operating Margin, YoY Annual Change (%)

Niagen Bioscience, Inc. Quarterly Operating Margin (%)

Period Value YoY Chg Change % Start Date End Date
Q3 2025 15% +15% +3074% 01 Jul 2025 30 Sep 2025
Q2 2025 14% +17% 01 Apr 2025 30 Jun 2025
Q1 2025 12% +18% 01 Jan 2025 31 Mar 2025
Q4 2024 7.8% +14% 01 Oct 2024 31 Dec 2024
Q3 2024 0.49% +8.7% 01 Jul 2024 30 Sep 2024
Q2 2024 -2.7% +8.2% +75% 01 Apr 2024 30 Jun 2024
Q1 2024 -5.2% +11% +68% 01 Jan 2024 31 Mar 2024
Q4 2023 -6.7% +19% +74% 01 Oct 2023 31 Dec 2023
Q3 2023 -8.2% +24% +75% 01 Jul 2023 30 Sep 2023
Q2 2023 -11% +30% +73% 01 Apr 2023 30 Jun 2023
Q1 2023 -17% +23% +58% 01 Jan 2023 31 Mar 2023
Q4 2022 -26% +14% +36% 01 Oct 2022 31 Dec 2022
Q3 2022 -33% +10% +23% 01 Jul 2022 30 Sep 2022
Q2 2022 -41% -3.5% -9.5% 01 Apr 2022 30 Jun 2022
Q1 2022 -39% -3.4% -9.5% 01 Jan 2022 31 Mar 2022
Q4 2021 -40% -6.6% -20% 01 Oct 2021 31 Dec 2021
Q3 2021 -43% -3% -7.4% 01 Jul 2021 30 Sep 2021
Q2 2021 -37% +8.8% +19% 01 Apr 2021 30 Jun 2021
Q1 2021 -36% +21% +37% 01 Jan 2021 31 Mar 2021
Q4 2020 -34% +34% +50% 01 Oct 2020 31 Dec 2020
Q3 2020 -40% +33% +45% 01 Jul 2020 30 Sep 2020
Q2 2020 -46% +38% +45% 01 Apr 2020 30 Jun 2020
Q1 2020 -57% +38% +40% 01 Jan 2020 31 Mar 2020
Q4 2019 -68% +38% +36% 01 Oct 2019 31 Dec 2019
Q3 2019 -73% +28% +28% 01 Jul 2019 30 Sep 2019
Q2 2019 -84% +5.8% +6.4% 01 Apr 2019 30 Jun 2019
Q1 2019 -95% -12% -14% 01 Jan 2019 31 Mar 2019
Q4 2018 -105% -28% -36% 01 Oct 2018 31 Dec 2018
Q3 2018 -101% 01 Jul 2018 30 Sep 2018
Q2 2018 -90% 01 Apr 2018 30 Jun 2018
Q1 2018 -83% 31 Dec 2017 31 Mar 2018
Q4 2017 -77% 01 Oct 2017 30 Dec 2017

Niagen Bioscience, Inc. Annual Operating Margin (%)

Period Value YoY Chg Change % Start Date End Date
2024 7.8% +14% 01 Jan 2024 31 Dec 2024
2023 -6.7% +19% +74% 01 Jan 2023 31 Dec 2023
2022 -26% +14% +36% 01 Jan 2022 31 Dec 2022
2021 -40% -6.6% -20% 01 Jan 2021 31 Dec 2021
2020 -34% +34% +50% 01 Jan 2020 31 Dec 2020
2019 -68% +38% +36% 01 Jan 2019 31 Dec 2019
2018 -105% -28% -36% 31 Dec 2017 31 Dec 2018
2017 -77% 01 Jan 2017 30 Dec 2017
* An asterisk sign (*) next to the value indicates that the value is likely invalid.